Relacorilant, Navepegritide And Icotrokinra Among Latest EU Filings

 
• By Neena Brizmohun
  
plaque psoriasis
The EMA has received a new batch of drug marketing applications for review (Shutterstock)

More from Product Reviews

More from Pink Sheet